Retina/Vitreous News

CHICAGO — In this Healio Video Perspective from the AAO meeting, Allen C. Ho, MD, of Wills Eye Hospital shares promising results of a phase 2b/3 trial investigating MCO-010 optogenetic therapy for the treatment of retinitis pigmentosa.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Pravin U. Dugel, MD, of Ocular Therapeutix discusses the next steps for the phase 3 SOL-1 and SOL-R studies.

CHICAGO — Teleretinal screening for diabetic retinopathy has several benefits, including increased capacity and better compliance, according to a speaker at the American Academy of Ophthalmology meeting.

Adalimumab combined with corticosteroids led to a significantly lower rate of relapse in Behçet’s disease uveitis vs. cyclosporine alongside corticosteroids, according to data published in The Lancet Rheumatology.

CHICAGO — Different imaging modalities are effective for the diagnosis of geographic atrophy, according to a speaker at the American Academy of Ophthalmology meeting.

CHICAGO — Decreasing vitamin A dimerization may be a promising treatment avenue for treating geographic atrophy, according to a speaker here.

CHICAGO — A Fas inhibitor showed strong efficacy signals and demonstrated neuroprotection in patients with more than 8 days of macula-off rhegmatogenous retinal detachment, according to a study.

CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Jeremiah Brown, MS, MD, presents results from the phase 4 Elevatum trial investigating faricimab for diabetic macular edema.

CHICAGO — Physicians and engineers need to work together to advance surgical technology, according to a speaker at Retina Subspecialty Day at the American Academy of Ophthalmology meeting.

In this video, Barbara Blodi, MD, discusses early data on neuroprotective agents for the treatment of geographic atrophy.